Attenuation of microglial aryl hydrocarbon receptor alters astrocyte activation and chronic pain sensitization in

Jia-Xiao Sun1, Ying Huang1, Juan-Juan Zheng2

  • 1Department of Anesthesiology, Quanzhou First Hospital, Fujian Medical University, Quanzhou, 362000, China.

Open Life Sciences
|February 23, 2026
PubMed

Insights

Aryl hydrocarbon receptor (AHR) expression is lower in aged microglia, increasing inflammation and chronic pain sensitization. Attenuating microglial AHR exacerbates astrocyte activation and hyperalgesia in aging mice.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Microglia play a crucial role in neuroinflammation and pain sensitization.
  • Aryl hydrocarbon receptor (AHR) signaling is implicated in immune cell function.
  • Age-related changes in microglial function contribute to chronic pain.

Purpose of the Study:

  • To compare aryl hydrocarbon receptor (AHR) expression in microglia from aged versus adult mice.
  • To investigate the role of microglial AHR in chronic pain sensitization.
  • To determine the impact of microglial AHR attenuation on astrocyte activation and neuroinflammation.

Main Methods:

  • Immunofluorescence staining to quantify AHR expression in microglia.
  • In vitro treatment of BV2 microglial cells with LPS, AHR agonist (FICZ), and antagonist (CH223191).
  • Co-culture of treated microglia supernatant with C8-DIA astrocytes and quantification of inflammatory factors via qPCR.

Main Results:

  • AHR expression in spinal dorsal horn microglia was significantly reduced in aged mice compared to adult mice.
  • Diminished microglial AHR expression led to increased astrocyte activation.
  • Activated microglia with reduced AHR expression enhanced astrocyte-mediated inflammation, contributing to prolonged hyperalgesia.

Conclusions:

  • Reduced microglial AHR expression in aged mice is associated with heightened neuroinflammation and chronic pain.
  • Microglial AHR signaling modulates astrocyte activation and inflammatory responses.
  • Targeting microglial AHR may offer a therapeutic strategy for age-related chronic pain.